Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGESELSKABET HERLEV HUDKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   3.3% 3.2% 4.7% 5.1% 3.4% 2.1% 10.0% 10.0%   Credit score (0-100)   56 56 44 43 53 68 25 25   Credit rating   BBB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,087 5,356 4,625 4,685 5,424 5,879 0.0 0.0   EBITDA   549 620 -201 1,313 300 435 0.0 0.0   EBIT   482 556 -267 1,239 231 332 0.0 0.0   Pre-tax profit (PTP)   479.0 553.0 -274.0 1,240.0 224.4 339.1 0.0 0.0   Net earnings   370.0 430.0 -216.0 964.0 171.8 263.0 0.0 0.0   Pre-tax profit without non-rec. items   479 553 -274 1,240 224 339 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   389 358 385 446 921 895 0.0 0.0   Shareholders equity total   734 1,105 825 1,721 1,768 1,722 1,505 1,505   Interest-bearing liabilities   7.0 29.0 9.0 10.0 9.7 9.8 0.0 0.0   Balance sheet total (assets)   1,243 2,405 1,278 2,182 2,490 2,140 1,505 1,505   Net Debt   -437 -1,379 -129 -1,327 -1,029 -537 -1,505 -1,505     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,087 5,356 4,625 4,685 5,424 5,879 0.0 0.0   Gross profit growth   3.1% 31.0% -13.6% 1.3% 15.8% 8.4% -100.0% 0.0%   Employees   4 4 4 5 5 5 0 0   Employee growth %   0.0% 0.0% 0.0% 25.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,243 2,405 1,278 2,182 2,490 2,140 1,505 1,505   Balance sheet change%   55.6% 93.5% -46.9% 70.7% 14.1% -14.0% -29.7% 0.0%   Added value   549.0 620.0 -201.0 1,313.0 304.8 434.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -65 -95 -39 -13 406 -128 -895 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.8% 10.4% -5.8% 26.4% 4.3% 5.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   47.2% 30.5% -14.5% 71.7% 9.9% 14.6% 0.0% 0.0%   ROI %   63.3% 49.8% -24.0% 92.6% 12.8% 18.6% 0.0% 0.0%   ROE %   64.2% 46.8% -22.4% 75.7% 9.9% 15.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   59.1% 45.9% 64.6% 78.9% 71.0% 80.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -79.6% -222.4% 64.2% -101.1% -343.3% -123.5% 0.0% 0.0%   Gearing %   1.0% 2.6% 1.1% 0.6% 0.6% 0.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.3% 16.7% 36.8% 10.5% 65.9% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.3 1.8 2.1 3.9 2.3 3.2 0.0 0.0   Current Ratio   2.3 1.8 2.1 3.9 2.3 3.2 0.0 0.0   Cash and cash equivalent   444.0 1,408.0 138.0 1,337.0 1,039.1 546.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   441.0 851.0 435.0 1,228.0 845.0 763.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   137 155 -50 263 61 87 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   137 155 -50 263 60 87 0 0   EBIT / employee   121 139 -67 248 46 66 0 0   Net earnings / employee   93 108 -54 193 34 53 0 0